Showing 1691-1700 of 19301 results for "".
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
https://reachmd.com/programs/frontlines-prostate-cancer/personalizing-prostate-cancer-surveillance-insights-from-canary-pass/32224/For patients with early-stage prostate cancer, routine clinical variables like Gleason scores or PSAs have their limits. The Canary Prostate Active Surveillance Study (Canary PASS) is reshaping our management approach through improved risk stratification. Dr. Lisa Newcomb joins us to explain the finRecognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
https://reachmd.com/programs/living-rheum/recognizing-and-addressing-rheumatic-iraes-from-cancer-immunotherapies/32791/Patients who are receiving immunotherapy for cancer sometimes develop significant autoimmune complications, which can be fatal. Join Dr. Laura Cappelli, Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine, as she explains how multidisciplinary collaboratioMasterclasses in Dermatology: The Importance of Interdisciplinary Teaching
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/masterclasses-in-dermatology-the-importance-of-interdisciplinary-teaching/33021/Masterclasses in Dermatology 2025 course directors Alice Gottlieb, MD, a dermatologist and rheumatologist at Mount Sinai, and Joseph Merola, MD, MMSc, chair and professor of dermatology at UT Southwestern Medical Center in Dallas, talk about the value of interdisciplinary education and collaborationSpotting the Signs: Early Identification and Management of Schizophrenia
https://reachmd.com/programs/frontlines-schizophrenia/spotting-the-signs-early-identification-and-management-of-schizophrenia/30031/Early signs of schizophrenia can be difficult to detect, but knowing the signs can help improve outcomes. Here’s what you should know.Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/promising-results-for-investigational-antisense-oligonucleotide-treatment-for-dravet-syndrome-1/35435/Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.Extraintestinal Manifestations of IBD: Evaluation and Management Strategies
https://reachmd.com/programs/gi-insights/extraintestinal-manifestations-of-ibd-evaluation-and-management-strategies/27077/Hear how to properly evaluate and manage patients with extraintestinal manifestations of inflammatory bowel disease.A Quick Guide: Principles of Trauma-Informed Care
https://reachmd.com/programs/clinicians-roundtable/tbd/15698/How can clinicians improve trauma patient care in the ED? Read more.Illinois House Bill Protects Physician Mental Health
https://reachmd.com/programs/clinicians-roundtable/illinois-house-bill-protects-physician-mental-health/15465/Illinois recently passed a bill aimed at protecting physicians’ mental health. Here’s what you need to know.Gravity & the Gut: Exploring a Key Hypothesis for IBS
https://reachmd.com/programs/gi-insights/gravity-the-gut-exploring-a-key-hypothesis-for-ibs/14613/Find out more about a possible cause of IBS, and how it might impact treatment.Exploring Therapeutic Drug Monitoring in IBD
https://reachmd.com/programs/gi-insights/exploring-therapeutic-drug-monitoring-in-ibd/13463/What do we need to know about therapeutic drug monitoring for patients with irritable bowel disease?